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Potassium para-aminobenzoate was tested for its abil-
ity to affect growth and macromolecule synthesis in vitro 
using fibroblasts from normal human skin, from affected 
skin of patients with scleroderma, and rheumatoid syn-
ovial cells. The proliferation of all 3 cell types showed 
dose-dependent inhibition b eginning at about 3000 p.g/ 
ml. Acid mucopolysaccharide secretion by rheumatoid 
synovial cells and scleroderma fibroblasts was inhibited 
even at 100 p.g/ml, which is within the therapeutic range, 
and there was over 50% inhibition at 5000 p.g/ml. Colla-
gen synthesis by several different strains, was not af-
fected, despite the use of a range of concentrations and 
treatment t imes. 
Potassium para-amino benzoate (KPAB) has been used to 
treat many connective t issue disorders. Not all reports have 
been encouraging but successful results have been claimed in 
scleroderma [1 ,2], dermatomyosit is [3], the pulmonary fibrosis 
of sarcoidosis [4]. Peyronie's disease [5,6] and rheumatoid ar-
thritis [7], using regimes in which KP AB was combined with 
other fo rms of therapy. The mode of action of the drug is 
unknown but Zarafonetis [1] suggested that its apparent anti-
fibrotic effect may involve increased monoamine oxidase activ-
ity; and experimental studies have demonstrated increased 
oxygen uptake by rat, mouse and chick tissues [8,9]. Further 
understanding of para-amino benzoate's action on connective 
tissue is clearly required. 
We have tested the drug's effect on cell proliferation, acid 
mucopolysaccharide secretion, and collagen and other protein 
synthesis in cultures of normal skin fibroblasts, fibroblasts from 
the affected skin of scleroderma patients and rheumatoid syn-
ovial cells. 
MATERIALS AND METHODS 
Sources of Cells 
Normal skin fibroblasts were obtained from the Royal Hospi tal for 
Sick Children, Edinburgh, where they had been grown from infant 
foreskin; these cells were designated HSF3-6. Rheumatoid cell stra ins 
(designated RAl-6) were grown from synovium obtained by elbow or 
knee synovectomy of rheumatoid arthri tis patients (average age 60). 
Two scleroderma cell s trains were grown from fragments of skin biop-
sies made for the histological diagnosis of systemic sclerosis. T he 
patient for SD3 was female, aged 52, with spreading inflamed lesions 
on her limbs; she had begun systemic steroid t reatment severa l days 
before the biopsy was taken from her upper arm. T he IJatient for SD6 
was a lso female, aged 32, and had active fibrotic lesions on hands a nd 
arms. T he biopsy was from her arm; she had not received any drugs. 
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Grow/h of Cells 
Tissue was chopped into 1-mm fragments which were then arranged 
on the bottom of a plastic Petri dish a nd covered by a glass coverslip. 
Growth medium (see below) which contained 20% serum for the first 7 
days, was added, and the dishes were mainta ined in a n atmosphere of 
5% CO" in air at 37° for at least 2 weeks un til the fibroblast outgrowth 
was sufficiently thick. The cells were t hen suspended with t rypsin-
versene and t ransferred to plastic culture flasks for routine propagation. 
HSF strains were used at passages 7-22, RA strains at passages 7-14 
and SD stra ins at passages 5-10. 
Cells were grown in Fa lcon plastic fl asks flushed with 5% CO" in air 
a t 37°. Du lbecco-Eagle medium conta ining 10% feta l calf serum, 4 mM 
glutamine, 100 units/ ml penicillin and 100 Jlg/ ml streptomycin (Gibco-
Biocult, Ltd. , Paisley, Scotland) was replaced on alternate days. Cells 
were harvested with t rypsin-versene for coun t ing in an electronic cell 
coun ter (Coulter Model DN) . 
Proliferation Tests 
T he method resembled that used in previous work [10,11]' On Day 
0, 28 fl asks (each 25 cm" growth a rea) were seeded with aliquots of cells 
(about 1 x 10"). On Day 3, four flasks were withdrawn for cell coun ts 
while the rest were grouped in 4s for treatment with KPAB at 5 
concentrations (10,100,1000,5000 and 10000 Mg/ ml) with a second con-
tro l group. Media were renewed on Day 4, and on Day 6 cell numbers 
were counted in all flasks. The increa e in cell number in media 
containing KPAB was expressed as a percentage of increase in cell 
number in cont rols between Days 3 a nd 6. 
Acid M ucopolysaccharide Secretion 
Medium in troduced on Day 4 and collected on Day 6 of proli feration 
te ts, and 1 ml of buffered saline used to rinse the cell layers, was 
dialyzed against 0.1 M sodium acetate buffer, pH 4.9 fo r 3 days and 
concentra ted to a bout 3 ml by adding Lyphogel (Gelman-Hawksley 
Ltd.) . Each sample was digested with 2 mg hyaluronidase (Sigma, Type 
I) overnight at 37°C before precipi tation of prote in at 4°C in 5% 
t richloracetic acid (TCA) . Uronic acid was assayed in supernatants 
a fter cent rifugation at 18000 g for 30 min using metahydroxydiphenyl 
reagent [121 with a glucoronolactone standard. Uronic acid output from 
each cul ture was determined by subt racting the uronic acid content of 
each batch of medium (assayed a long wi th experimenta l samples) a nd 
output per 107 cells was calculated from the cell coun ts recorded in 
proli feration tests. 
Collagen Synthesis 
Synthesis of collagen and other prot.ein was assessed in confluent 
cul tures of SD3, SD6 a nd HSF6 cells grown in plastic l11ul t iwell dishes 
in medium containing 50 Jlg/ ml ascorbic acid . Total protein synthesis 
was monitored by incorporation of "H-proline, and collagen synthesis 
as incorporation of "H-proline into collagenase-sensitive protein. 
Each experiment used 5 or 6 dishes. In each dish 3 wells served as 
cont rols a nd 3 rece ived K PAB; ma terial from similarly-treated wells 
was subsequently pooled so that each dish provided 1 t reated a nd 1 
control sample, each comprising separated cells and medium. In t he 
main series of experiments, with SD3 cells, each well received 1 ml of 
medium (without antibiot ics or serum) containing 10 JlCi [5-H"] proline 
(Radioch9mical Centre, Amersha m, E ngland) with or without KPAB , 
and the dishes were incubated at 37°C for 16 h r. The cultures were 
then cooled to 4°C and the medium withdrawn. To the medium was 
added 1 ml of buffered saline used to rinse the cells, which were next. 
allowed to swell in 1 ml distilled water for 30 min, then removed from 
the dishes with a jet of distilled water and passed through a fin e 
hypodermic needle several times, which effectively homogenized them. 
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Carrier protein (one drop 1 % serum albumin) was added to each sample, 
and then TCA to a final concentration of 5%. Protein precipitates were 
collected by centrifugation at 2000 rpm (4 °C) and washed successively 
with ethanol containing 2% sodium acetate, ethanol-ether (3:1) and 
ether. The dry pellets were redissolved in 0.5 ml 0.2 N KOH, neutralized 
with 0.2 ml 0.4 N HCI and diluted with 2 ml Tris-HCl buffer pH 7.6 
containing 10 mM calciu m chloride for division into 2 aliquots. One 
aliquot was incubated with 100 uni ts of collagenase (Advance Biofac-
tures Corp., Lynbrook, New York) overnight at 37°C, while the other 
aliquot was incubated with buffer. Protein was then reprec ipi tated in 
5% TCA containing 0.25% tannic ac id , washed as before and dried. 
Residues were dissolved in hya mine hydroxide, acidified with glacial 
acetic ac id and added to 10 ml NE233 scintillation mixture (N uclear 
Enterprises, Edinburgh, Scotland) for liquid scintillation counting. A 
quench correction by external standard channels ra tio was used to 
convert cpm to dpm. 
As collagenase from this source is free from proteases [13] all 
radioactivity dispersed by the enzyme was regarded as collagen. The 
proportion of the total protein-bound radioactivity present in the 
medium as opposed to in the cell layer was expressed as percentage 
secretion. Relative collagen synthesis, the proportion of total protein 
synthesis which is collagen, was calculated by the method of Diegel-
mann and Peterko fsky [14]. 
RESULTS 
The proliferation of a ll 3 cell types showed a common pattern 
of response to KPAB (Fig 1) . Two cell strains, HSF4 and SD3 
showed some growth inhibition (p < 0.05) at low KP AB con-
centrations-lO and 100 Ilg/ml-but the main effect was seen 
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at 5000 a nd 10000 Ilg/ml. The shape of the curves suggested a 
dose-related response from about 3000 Ilg / ml onwards, and this 
was confirmed later with SD6 cells using intermediate drug 
concentrations (Fig 1, bottom). ID,,!) values, representing 50% 
inhibition of cell proliferation, were therefore read from the 
curves between the 5000 a nd 10000 points, except with HSF3 
and HSF6 cells where slight extrapolation was used . The ID"t) 
values lay in the 4500-6700 Ilg/ml range, with normal skin 
fibroblasts slightly lower than the abnormal cells (HSF strains 
4925 ± 165 (mean ± SE; n = 4), and RA strains 6225 ± 189 (p 
< 0.01); SD strains: SD3 5800, SD6 6500. 
Acid mucopolysaccharide secretion was depressed at even 10 
Ilg/ml in 3 of the 4 RA cell strains tested (Fig 2). Inhibi t ion 
increased wit h KP AB concentration except at 10000 Ilg/ ml 
where the results may be distorted by the low number of cells 
counted at the end of t he experiment. For instance RA1 cells 
gave higher values for output/ 107 cells at 10000 Ilg/ml KPAB 
t han the controls, despite a 51% lower m onic acid content in 
t he medium. It is not clear why only some strains should show 
this effect. The correlation coefficient for pooled results from 
all 4 strains (n = 16 at each concentration) was -0.34 (p < 
0.001) with 10000 Ilg/ml values included. Inhibition of acid 
mu'copolysaccharide secretion in scleroderma fibroblasts was 
within the limits shown in Fig 2 for the RA cell strains. SD3 
cells showed more inhibit ion than SD6, but a plot of pooled 
data (SD3 and SD6, n = 8 at each drug concentration) was 
a lmost indistinguishable from that of the RA stra ins shown in 
F ig 3 except that the value at 10000 Ilg/ ml was only 12% of 
controls; a correlation coefficient for this data was -0.75 (p < 
0.001). Statistical comparison of pooled results at 100 Ilg KP AB/ 
ml with controls (Studen t's t test) showed p < 0.02 for RA 
strains a nd p < 0.05 for SD strains. 
Collagen synthesis was not affected in SD3 cells treated with 
KPAB at 1000, 3000 or 5000 Ilg/ ml for 16 hI' (Table, part A) , 
but incorporation into other protein was slightly higher. This 
meant that relative collagen synthesis values for 3000 and 5000 
Ilg/ ml were lower in KPAB-treated cultures. Secretion of col-
lagen a nd other protein was not disturbed by KP AB treatment: 
about 85% of collagenous protein and 35% of other radioactively 
la beled protein appeared in the medium. 
N egative results of the collagen assays could have several 
a lternative explanations. To try to exclude some of these, 4 
addi t ional experiments were performed. First, SD3 cells were 
given longer t reatment (2.5 days of KPAB wit h :JH-proline 
incorporation measured over the final 16 hr) . Second, HSF6 
fibrobl asts, in which collagen synthesis is sensitive to cortico-
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FIG l. Effect of KPAB on cell proliferation in normal skin fibro-
blasts (HSF) , rheumatoid synovial cells (RA) and scleroderma skin 
fibroblasts (SD). Curves represent individual cell strains with each 
point a mean (±SE) from 4 cul tures. Proliferation of untreated control 
cul tures = 100. 
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FI G 2. Effect of KPAB on acid mucopolysaccharide secretion by 4 
rheumatoid cell strains. Each point is a mean from 4 cultures (±SE). 
Secretion by untreated cultures = 100. 
April1979 
steroids [11] were treated with KPAB. Third, SD3 fibroblasts 
were treated with clobetasol propionate under the conditions 
w hich depress collagen synthesis in HSF6. Finally, a second 
strain of scleroderma fibroblasts, SD6, was treated with KP AB. 
In each case the effect on collagen and other protein synthesis 
was monitored as before. The results (Ta ble, part B) s how that 
the response to KP AB was again limited to a slight stimulation 
of non collagen protein synthesis, with no effect on collagen 
synthesis. Treatment of SD3 cells with clobetasol propionate 
for only 5 hr reduced both collagen and other protein synthesis 
by over 50%, an even greater reduction t han that produced 
previously in HSF6 under identical conditions [11]. The similar 
responses of SD3, SD6 and HSF6 to KP AB, and the SD3 
strain's rapid response to clobetasol propionate confirm that 
SD3 cells are competent to show inhibition of collagen synthesis 
50 
10 
IlrolJablc blood lc\'c ls 
¢ dudng Iher:,p}' ;> 
100 
KPAI) Ij~ / 1\\1 
1000 
, 
, 
, 
" '~ 
\ 
\ 
\ 
\ 
FIG 3. Summary of KPAB effects. Cell proliferation (solid circles) 
is shown as a s ingle curve represen t ing all 10 cell strains (n = 40) for 
each point shown in Fig I. Acid mucopolysaccharide secretion (open 
circles ) is shown as a curve representing all the results from RA strains 
in Fig 2 (n = 16 for each point). Collagen est imations (aslerishs) are 
those on SD3 cells treated for 16 hr (Table, part A). 
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in response to a sufficiently potent drug, and make it seem very 
unlikely that para-aminobenzoate affects collagen synthesis. 
DISCUSSION 
Anti-inflammatory and antirheumatic drugs can affect acid 
mucopolysaccharide secretion, protein synthesis and cell prolif-
eration in fibroblast cul tures, and in intact connective tissues in. 
vivo [15-17]. Para-aminobenzoate should belong with this class 
of compound since its recommended uses have included the 
treatment of rickettsial fevers, scleroderma and rheumatoid 
arthritis [1]. In cell cultures these drugs depress acid mucopol-
ysaccharide secretion at much lower drug concentrations than 
protein synthesis or cell proliferation [18]. In our study acid 
mucopolysaccharide secretion by rheumatoid synovial cells and 
scleroderma fibroblasts was significantly depressed at 100 f1.g / 
ml, which is within the range of blood levels achieverl in KP AB 
therapy (C. J . D. Zarafonetis, personal communication ), while 
cell proliferation was not nota bly affected until about 3000 f1.g / 
ml, and even at 5000 f1.g / ml there was no statistically ignificant 
inhibit ion of collagen or other protein synthesis in nongrowing 
cultures of fibroblasts from normal or sclerotic skin. 
N egative findin gs are rarely conclusive in themselves and we 
have considered several explanations for the lack of effect on 
collagen synthesis. Fi.rstly, the SD3 cell strain may be unchar-
acteristic of scleroderma fibroblasts. Scleroderma fibroblasts 
have usually [1 9- 21] but not invariably [22] been found to 
produce more collagen than normal skin fibroblasts in culture 
but the difference may depend on the biopsy site within th e 
lesion and the current activity of the disease. Herbert et al. [20] 
report that penicillamine inhibits collagen synthesis only in the 
most active stage of scleroderma. The SD3 cells were less active 
than some normal skin fibroblasts we have used [10-11], (Table) 
as judged both by proliferation and collagen synthesis, but a 
more active strain SD6 gave the same results as SD3. Slow 
growth of scleroderma fibroblasts (as in SD3 but not SD6) has 
been reported previously [19,22] and can be corrected by in-
creasing the serum content of the medium [23], but we h ave 
avoided direct comparisons with normal skin fibroblasts be-
cause our HSF strains were from much younger donors and 
were not matched for sex or body site. It is significant that 
HSF6, a normal strain which responds to clobetasol propionate 
TABLE A. Effect of KPAB treatment for 16 hr on. collagen. and other protein -synthesis in SD3 scleroderma fibroblasts (n = 5) 
Group 
Treated 
Contro l 
Treated 
Control 
Treated 
Control 
KPAB in 
I'g/ ml 
1000 
3000 
5000 
Coll age n 
synlheRis, 
dpm 
34441 
28527 
47731 
52228 
35690 
37801 
" p < 0.05 s tudent's t test; other differences not significant. 
Othe r prot.e in 
sy nthesis. 
dpm 
112920 
] 12368 
193739" 
163057 
155877 
140407 
Relative Co llage n Othe r prote in coll agen 
synthes is. ~ecre t.jon. secre tion, 
% % % 
5.4 79 37 
4.5 78 33 
4.4 94 32 
5.7 82 31 
4.2 97 36 
4.9 83 38 
TABLE B. Effects on collagen and other protein synthesis of KPAB or clobetasol propionate (ep) in various cell strains (n = 6). 
SD3 cells 
Treated 
Control 
HSF6 cells 
Treated 
Cont ro l 
SD3 cells 
Treated 
Control 
SD6 cells 
Treated 
Contro l 
" p < 0.05. 
" p < om . 
' p < 0.001. 
3000 fo r 2.5 
days 
3000 for 2.5 
days 
CP 25 /-lg/ ml for 
5 hr 
5000 for 16 hr 
38543 
49708 
100820 
78860 
6353" 
15972 
75806 
535 10 
122749" 5Ji 77 42 
102268 8.3 71 4 1 
405976" 4.4 53" 33 
35 1370 4.0 92 24 
27682' 4.1 (j(i 25 
63190 4.5 86 22 
448187" 3.0 74 24 
344963 2.0 77 20 
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and betamethasone-17 -valerate with depressed collagen synthe-
s is [11] failed to do so with KPAB, while clobetasol propionate 
did rapidly depress collagen synthesis in SD3 cells . This shows 
that testing SD3 cells is valid . 
Could the treatment of cells with KPAB have been too short? 
Clinical experience shows slow improvement in patients over 
weeks or months [1-7]. For this reason treatment time was 
increased first to 16 hI', a 3-fold increase over our previous test 
routine with griseofulvin and corticosteroids [10-11], and finally 
to 2.5 days but even this showed no effect. 
Collagen synthesis was measured as incorporation of tritiated 
proline into collagenase-sensi tive protein and secretion of this 
radioactive protein from the fibroblasts into the culture me-
dium. The effects of KP AB on the later stages of collagen fiber 
assembly have not been tested and neither has the possibility 
that KP AB acts by increasing collagen breakdown. 
In our judgement these results make inhibition of collagen 
synthesis by KPAB seem very unlikely. KPAB-treated condi-
tions may, of course, respond through an effect on some other 
aspect of connec;tive tissue metabolism. For instance rheuma-
toid synovial cells produce more acid mucopolysaccharide than 
normal synovial cells, and this is an important feature of the 
disease [24]. The reduction of acid mucopolysaccharide synthe-
s is brought about by KP AB (Fig 2 and 3) could influence skin 
thickness and joint mobility by decreasing water binding to 
hyalUTonic acid in dermis and synovial fluid, or by affecting 
functioning of the fibrous component of the tissue. It seems 
very likely that when measured over a relatively long period, 
like 2 days, depression of acid mucopolysaccharide secretion 
involves inhibition of synthesis. In cultures of human skin 
fibroblasts treated with corticosteroids there were parallel falls 
in uronic acid in cells and medium [25] and the cells appear to 
have relatively little storage capacity for this material. 
The precise nature of the biochemical lesions in scleroderma 
is e lusive. Most recent work supports an increased turnover of 
collagen [19-21] but the actual content of collagen in skin 
remains unaltered [26]. The "antifibrotic" action of KPB was 
suggested [1] after the observation of greater skin flexibility 
and joint mobility, but direct evidence of changes in collagen 
content, composition or disposition through biochemical or 
histological analysis of biopsies from KPAB-treated skin have 
not been obtained. The most impressive action of KP AB to be 
seen in these experiments is depression of acid-mucopolysac-
charide secretion, and this effect would appear to be the most 
promising area for further study of the drug's pharmacology. 
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